Articles tagged with Cancer Treatments
Researchers found a significant association between IL28B genotypes and interferon-based antiviral treatment outcomes, as well as graft inflammation caused by hepatitis C virus (HCV). The presence of G-allele serves as a marker for severe HCV-induced graft inflammation and predictor of unsuccessful treatment.
Researchers at St. Jude Children's Research Hospital have identified a protein called FLIP as playing a pivotal role in controlling programmed cell death pathways, offering new potential targets in the fight against cancer and virus-infected cells.
By analyzing CD8+ T cells from healthy blood donors, researchers created a statistical model that accurately predicts the age and quality of T cells. This allows clinicians to transfer only young functional cells back into patients' bodies, potentially improving therapeutic outcomes for various cancers.
Breast cancer is a significant global health issue, with most deaths occurring in low- and middle-income countries. A Personal View published in The Lancet Oncology suggests that population-based mammography screening is not practical or cost-effective in these countries.
A new study found that uterine fibroid treatment significantly improved quality of life for women, with non-minimally invasive options such as MRgFUS showing better outcomes. The study surveyed over 197 women who underwent different treatments, including hysterectomy and UAE.
A new gene expression test distinguishes between metastasizing and non-metastasizing head and neck cancers with high accuracy. The test was validated in a large multi-center cohort, predicting the absence of metastasis in 89% of cases.
A study found that women with melanoma report higher levels of both positive and negative impacts of cancer, including increased worries about UV radiation. Women also adjust their sun behavior more often and experience difficulties in getting life insurance as a result of their diagnosis.
A new quadruple therapy regimen with omeprazole and a three-in-one capsule has been shown to be more effective in eradicating Helicobacter pylori infection than the standard 7-day treatment regimen. The study found that eradication rates were 80% for the quadruple therapy group versus 55% for the standard therapy group.
A team of internationally recognized molecular biologists, epidemiologists, and clinicians have been honored for their groundbreaking work on human papillomavirus (HPV) research. Their collaborative efforts have led to significant advances in understanding HPV's role in cancer development and the development of the HPV vaccine.
A new study found that cardiac resynchronization therapy with defibrillator (CRT-D) is significantly more beneficial for women than men in preventing heart disease. Women experienced a 70% reduction in heart failure and a 72% reduction in death, compared to 35% and 45%, respectively.
Researchers have developed a new method for treating genetic diseases using modified mRNAs, which can be administered repeatedly without increasing the risk of cancer or severe immune reactions. In mouse models, this technique successfully restored lung function in mice with a congenital lung defect.
A new therapeutic vaccine has shown a significant response in the majority of AIDS patients, with a decrease in viral load. The vaccine, developed by the Hospital Clinic of Barcelona-IDIBAPS, uses patient's own dendritic cells and has achieved an improvement over previous initiatives.
A deficiency in a protein that fends off aging-related cellular damage may set the stage for estrogen and progesterone receptor-positive breast tumors to develop. Researchers have identified a link between this protein and increased levels of reactive oxygen species, providing a potential biomarker for these tumors.
A study published in JAMA reveals that chromosome changes disrupt a molecular network influencing CLL outcome, providing new targets for treatment. Patients with 13q deletion generally have better prognosis than those with 11q or 17p deletions.
A new study reveals that COPD patients on LTOT are at a higher risk of death from non-respiratory causes such as cardiovascular disease. The study found an increase in mortality due to circulatory and digestive organ diseases, emphasizing the importance of optimized diagnostics and treatment.
Research suggests that breastfeeding can partially offset negative side effects of childhood cancer treatment, including impaired growth and reproductive difficulties. Women who have survived childhood cancer should be advised to breastfeed if they can, as it may help protect them against lasting effects of cancer treatment.
The EurocanPlatform project aims to find more effective ways to prevent, detect and treat cancer. By combining resources and expertise, researchers hope to identify patients at risk for cancer and adapt therapies to individual circumstances.
Researchers have identified a gene, PBRM1, that is mutated in one in three patients with clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer. This discovery provides new insights into the biology of renal cancer and may lead to new therapeutic directions for treatment.
The Khalifa bin Zayed Al Nahyan Charity Foundation is granting $150 million to support genetic-analysis based research, diagnosis and treatment of cancer at the University of Texas M. D. Anderson Cancer Center.
Researchers have identified a frequently mutated gene, PBRM1, in one in three patients with the most common form of renal cancer. The gene is tied to two previously identified genes on chromosome 3 and plays a role in controlling cell growth and repairing DNA damage.
A study by German Cancer Research Center found that hormone replacement therapy and a lack of physical activity significantly increase breast cancer risk. Behavioral changes in these areas could prevent nearly 30% of postmenopausal breast cancers.
Research highlights the key role of estrogen signaling in maintaining energy balance, as well as the propagation of α-synuclein in Parkinson's disease. Additionally, a new immune cell activator has been identified to protect mice from tumors through an IFN-gamma-independent mechanism.
A new study links an oncometabolite to widespread gene expression alterations in brain cancer and leukemia, promoting tumorigenesis. The research suggests that targeting the metabolic pathway may guide the development of new cancer therapies.
Researchers at the Trudeau Institute and St. Jude Children's Research Hospital are studying white blood cell migration in response to viral infections, which could lead to improved vaccine strategies. The study has major implications for developing vaccines that promote immunity to respiratory infections.
The TEAM study found that sequential treatment of tamoxifen followed by exemestane yields a comparable disease-free survival rate to exemestane alone, yet with distinct side effect profiles. This implies the need to tailor treatment regimens for specific patient groups.
Ryan Salinas, a 2nd-year medical student at UCSF, received the Lucien Rubenstein Award for his outstanding research on histone demathylase JMJD3 as a potential treatment target for glioblastoma. The American Brain Tumor Association selected Salinas from a group of 10 Medical Student Summer Fellows.
A new NIH study projects that cancer costs will increase to at least $158 billion in 2020 due to the growing US population and cancer trends. The projected costs are based on an aging population and the introduction of new, expensive cancer treatments.
Researchers found that 5a-reductase inhibitors, used to treat BPH and hair loss, can cause significant adverse effects in some individuals, including loss of libido, erectile dysfunction, and depression. The study suggests that caution should be exercised before prescribing these medications to patients.
A study found that a behavioral training program significantly reduced incontinence episodes in men with persisting symptoms after radical prostatectomy. The program included pelvic floor muscle training, bladder control strategies, and fluid management, yielding a 55% reduction in incontinence episodes at 8 weeks.
Researchers have discovered the molecular mechanism of measles virus infection, which could lead to a targeted cancer therapy. The study found that modifying the attachment protein is crucial for infectivity, and this discovery brings the dream of using measles virus as a cancer weapon closer to reality.
Researchers at UCLA found that the Nrf2 protein, thought to protect against oxidative stress, actually promotes atherosclerosis by raising plasma cholesterol levels and increasing plaque formation in arteries. The study suggests that antioxidant therapies targeting this protein may not be as effective due to these additional mechanisms.
The Damon Runyon Cancer Research Foundation has awarded grants totaling $1.9M to 12 early-career researchers conducting innovative cancer research. The fellowships provide independent funding to support novel projects and enable recipients to pursue careers in cancer research.
Scientists have identified a protein biomarker that predicts the efficacy of hepatitis C treatment, enabling improved patient management. The discovery of IP-10 as a prognostic biomarker could lead to the development of a diagnostic test to distinguish between effective and ineffective treatments.
A recent study published in PLoS ONE found that Longevinex exerts a greater influence on genes than resveratrol, leading to improved heart health outcomes. The research demonstrated that Longevinex reduced the size of heart attacks and protected against cell death, while also improving microRNA activity.
Researchers found that arsenic trioxide inhibits the growth of medulloblastoma and Ewing sarcoma cell lines by blocking the Hedgehog/GLI1 signaling pathway. The compound improved survival in a mouse model of medulloblastoma, suggesting its potential as a therapeutic option.
A new study suggests that the presence of tumor cells in the circulating blood of patients with squamous cell cancer of the head and neck may predict disease recurrence and reduced survival. The study found a correlation between an increasing number of circulating tumor cells (CTCs) and a worse outcome.
Patients with oral squamous cell carcinoma who experience early or lymph node recurrence after initial treatment tend to have poorer outcomes. The study suggests that local recurrences within six months are associated with worse survival rates, while regional recurrences at longer intervals also negatively impact survival.
A new study found that black patients with early-stage liver cancer have a higher mortality rate than white patients, with median survival times ranging from 8-10 months. The disparity in treatment access also affects the survival rates of Hispanic and black patients compared to white patients.
A new study by Stanford University School of Medicine researchers found that expanded HIV screening and treatment could prevent up to 212,000 new infections over the next 20 years. The strategy of one-time screening for low-risk individuals and annual screening for high-risk individuals is cost-effective.
A recent study found racial disparities in liver cancer survival rates, with black patients experiencing higher mortality rates compared to white and Hispanic patients. Despite receiving similar treatments, black patients had a 12% increased rate of death, indicating poor access to care and subpar treatment outcomes.
Researchers at UAB found that robotic surgery for upper airway and digestive track malignant tumors is as effective as standard minimally invasive techniques, with a two-year survival rate of 86.3%. The study also showed improved swallowing function in patients.
The Elsevier Foundation has awarded grants to institutions in Africa and Asia for projects focusing on telemedicine, infrastructure-building, and the preservation of primary source content. The grants aim to improve access to health information and support global health development.
Researchers have discovered a protein that can prevent chronic tissue inflammation and boost the immune system. The therapeutic vaccine has been shown to effectively treat conditions like multiple sclerosis and rheumatoid arthritis.
Researchers found that ovarian cancer screening can only slightly reduce mortality rates, highlighting the need for prevention and better treatments. For high-risk women, targeted screening may offer more hope in reducing deaths from ovarian cancer.
Mr Davis McCarthy has won a $150,000 scholarship to undertake a PhD at UC Berkeley, focusing on developing statistical analysis techniques to help biologists understand the mechanisms of diseases such as cancer and diabetes. He aims to make significant scientific contributions internationally.
Scientists at King's College London have made a critical discovery about the role of beta-catenin in leukemia stem cells. By suppressing this protein, they were able to reverse leukaemic stem cells to a pre-leukaemic stage and 're-sensitize' resistant cells to treatment.
Incorporating ovarian cancer subtypes into screening models reduces predicted mortality rates. However, catching slower-growing cancers won't significantly impact deaths compared to more lethal tumors.
A study published in Neurology found that nearly 40% of brain tumor patients use alternative therapies, including homeopathic remedies and vitamin supplements. Younger people, women, and those with more education were more likely to use these treatments, which they often sought to add benefits to conventional care.
A study found that combining epigenetic therapy and molecular targeted therapy can improve outcomes for patients with elevated E-cadherin levels in advanced lung cancer. The treatment achieved significantly improved overall survival rates compared to erlotinib alone.
A La Jolla Institute team has validated a computer model's ability to predict key information on nasal insulin treatment regimens in type 1 diabetes. The platform accurately predicted biomarker onset and therapeutic outcome, confirming its potential as a valuable research tool.
A groundbreaking clinical trial is examining the safety of hypothermia in elderly stroke patients, aiming to improve outcomes and prevent neurological damage. The study, led by top researchers, will enroll 400 patients at multiple US and European sites and investigate the effectiveness of therapeutic brain cooling.
Researchers at Mayo Clinic found that JAK inhibitors CYT387 and TG101348 effectively reduce spleen size and alleviate constitutional symptoms in myelofibrosis patients. These targeted treatments have shown significant clinical benefits, including improved anemia rates and reduced white blood cell counts.
Researchers found that apixaban was more effective than enoxaparin in preventing major venous thromboembolism without increasing bleeding risk. This innovative treatment has improved methods for patients undergoing hip or knee replacement surgery, and may also be beneficial for cancer patients with VTE.
A study found that decreased physician reimbursement for hormone therapy reduced its use in low-risk prostate cancer cases by 40%. However, AST usage remained unchanged in patients with metastatic disease. The decrease is attributed to the real effect of reimbursement change.
A study presented at the Radiological Society of North America annual meeting found that diagnosis uncertainty can be as stressful as knowing a serious illness, with breast biopsy patients reporting significantly higher anxiety levels. Healthcare providers can alleviate patient stress by improving communication and shaping expectations.
A new study finds that a less invasive method for determining lung cancer stage improves detection of metastases and reduces surgical procedures. The method, which combines endosonography and ultrasound, was more effective than traditional surgical staging in identifying patients who needed further treatment.
A study published in Cancer Research reveals that microRNA-375 plays a crucial role in breast cancer cells, leading to increased estrogen receptor alpha levels. Blocking this microRNA effectively slows down cancer cell growth, offering potential new strategies for treatment.
During pregnancy, pregnant women can experience significant changes in their oral health, including gingivitis, pregnancy tumors, and mild to severe gingival enlargement. Regular dental check-ups and proper oral hygiene can help alleviate gum inflammation and prevent worsening of conditions.
A Johns Hopkins study found that delayed HIV treatment adds tens of thousands of dollars in care costs and reduces survival rates. Patients who wait too long to receive treatment require more expensive antiretroviral therapy, antibiotics, and hospitalizations.
High-throughput DNA sequencing of gut bacteria confirmed that antibiotic treatment disrupts bacterial patterns, which precedes VRE colonization and bloodstream invasion. Monitoring fecal bacteria content could identify patients at high risk of life-threatening infections.